Cargando…

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway

BACKGROUND: MT1G inactivation mediated by promoter methylation has been reported in thyroid cancer. However, the role of MT1G in thyroid carcinogenesis remains unclear. The aim of this study is to examine the biological functions and related molecular mechanisms of MT1G in thyroid cancer. METHODS: M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jiao, Lv, Hongjun, Guan, Haixia, Ma, Xiaoying, Ji, Meiju, He, Nongyue, Shi, Bingyin, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851544/ https://www.ncbi.nlm.nih.gov/pubmed/24098937 http://dx.doi.org/10.1186/1471-2407-13-462

Ejemplares similares

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
por: Shi, Jing, et al.
Publicado: (2012)

Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
por: Wang, Liping, et al.
Publicado: (2015)

CYP2S1 is a synthetic lethal target in BRAF(V600E)-driven thyroid cancers
por: Li, Yiqi, et al.
Publicado: (2020)

Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3
por: Lv, Yanyan, et al.
Publicado: (2016)

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
por: Shi, Jing, et al.
Publicado: (2012)

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer
por: Liu, Wei, et al.
Publicado: (2016)

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
por: Su, Xi, et al.
Publicado: (2019)

Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways
por: Xie, Jingyi, et al.
Publicado: (2023)

Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway
por: Hou, Bin, et al.
Publicado: (2020)

The Impact of Coexistent Hashimoto’s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
por: Russo, A J
Publicado: (2009)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012)

Upregulation of the PI3K/Akt Pathway in the Tumorigenesis of Canine Thyroid Carcinoma
por: Campos, M., et al.
Publicado: (2014)

TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway
por: Tang, Wenqing, et al.
Publicado: (2019)

c-Myc is Required for BRAF(V600E)-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
por: Qu, Yiping, et al.
Publicado: (2017)

The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K/AKT signaling pathway
por: Liu, Yazhuo, et al.
Publicado: (2017)

TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway
por: Jiang, Qiuli, et al.
Publicado: (2023)

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Neuroprotective effects of metformin on cerebral ischemia‐reperfusion injury by regulating PI3K/Akt pathway
por: Ruan, Cailian, et al.
Publicado: (2021)

MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling
por: Shen, Qiushuo, et al.
Publicado: (2022)

Gender-Specific Risk of Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Sun, Yushi, et al.
Publicado: (2018)

SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways
por: Ren, Xiaojuan, et al.
Publicado: (2023)

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
por: Dai, Youyi, et al.
Publicado: (2017)

Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
por: Hao, Xiang-lin, et al.
Publicado: (2019)

AMPH1 functions as a tumour suppressor in ovarian cancer via the inactivation of PI3K/AKT pathway
por: Chen, Yajun, et al.
Publicado: (2020)

PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling
por: Xiao, Hongmei, et al.
Publicado: (2020)

The PI3K/AKT pathway in obesity and type 2 diabetes
por: Huang, Xingjun, et al.
Publicado: (2018)

M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway
por: Lv, Juan, et al.
Publicado: (2021)

ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53
por: Li, Lanlan, et al.
Publicado: (2021)

Integrin αIIb-Mediated PI3K/Akt Activation in Platelets
por: Niu, Haixia, et al.
Publicado: (2012)

Comments to Metallothionein as an Anti-Inflammatory Mediator
por: Guan, Yong-Song
Publicado: (2009)

SYST-16 ANXA5 PROMOTES GLIOMA PROGRESSION THROUGH THE FAK/PI3K/AKT PATHWAY
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2‐knockout mice
por: Huang, Shan, et al.
Publicado: (2021)

CpG-ODN Attenuates Pathological Cardiac Hypertrophy and Heart Failure by Activation of PI3Kα-Akt Signaling
por: Yang, Liang, et al.
Publicado: (2013)

MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
por: Zhang, Jiale, et al.
Publicado: (2018)

ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways
por: Ma, Qing, et al.
Publicado: (2019)

Author Correction: Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
por: Hao, Xiang-lin, et al.
Publicado: (2019)

FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer
por: Su, Tianhong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_79chi11anmjq71a7n1f140kmgb